首页> 外文会议>Nanotechnology 2009 : Technical proceedings >Contrasting agent for magnetic resonance imaging based on nanostructural dispersion of Manganese derivative of phthalocyanine: preliminary investigation results
【24h】

Contrasting agent for magnetic resonance imaging based on nanostructural dispersion of Manganese derivative of phthalocyanine: preliminary investigation results

机译:基于酞菁锰衍生物纳米结构分散的磁共振成像造影剂:初步研究结果

获取原文
获取原文并翻译 | 示例

摘要

Contrast agents (CA) are used to increase contrast of tumors (especially metastases) during magnetic resonance imaging (MRI). The most applied group of CA is based on coordination complexes of paramagnetic ions, mostly Gadolinium and Manganese complexes [1]. In addition to high paramagnetic properties, efficient CA is supposed to selectively accumulate in tumor, quickly achieving its maximum content in tissue and retaining it for the duration of diagnostic procedure, while sufficiently fast (preferably in less than 24 hours) clear from the normal tissue (after the end of the procedure). The work is devoted to study of Manganese(III) chloride tetra-3-phenylthio-tetra-5-tert-buthylphthalocyanine [3-(PhS)_4-5-(t-Bu)_4PcMnCl] as potential CA for MRI.
机译:造影剂(CA)用于在磁共振成像(MRI)期间增加肿瘤(尤其是转移瘤)的对比度。最为广泛使用的CA组是基于顺磁性离子的配位化合物,主要是Ga和锰的配位化合物[1]。除了高顺磁性质外,高效的CA还应该选择性地在肿瘤中蓄积,迅速在组织中达到其最大含量,并在诊断过程中将其保留下来,同时从正常组织中清除得足够快(最好在24小时内)。 (在过程结束之后)。该工作致力于研究氯化锰(III)四-3-苯硫基-四-5-叔丁基丁基酞菁[3-(PhS)_4-5-(t-Bu)_4PcMnCl]作为MRI的潜在CA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号